These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24361683)

  • 1. Treatment as long-term prevention: sustained reduction in HIV sexual transmission risk with use of antiretroviral therapy in rural Uganda.
    Siedner MJ; Musinguzi N; Tsai AC; Muzoora C; Kembabazi A; Weiser SD; Bennett J; Hunt PW; Martin JN; Haberer JE; Bangsberg DR
    AIDS; 2014 Jan; 28(2):267-71. PubMed ID: 24361683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda.
    Bunnell R; Ekwaru JP; Solberg P; Wamai N; Bikaako-Kajura W; Were W; Coutinho A; Liechty C; Madraa E; Rutherford G; Mermin J
    AIDS; 2006 Jan; 20(1):85-92. PubMed ID: 16327323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV Transmission Risk Persists During the First 6 Months of Antiretroviral Therapy.
    Mujugira A; Celum C; Coombs RW; Campbell JD; Ndase P; Ronald A; Were E; Bukusi EA; Mugo N; Kiarie J; Baeten JM;
    J Acquir Immune Defic Syndr; 2016 Aug; 72(5):579-84. PubMed ID: 27070123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexual behavior and HIV transmission risk of Ugandan adults taking antiretroviral therapy: 3 year follow-up.
    Apondi R; Bunnell R; Ekwaru JP; Moore D; Bechange S; Khana K; King R; Campbell J; Tappero J; Mermin J
    AIDS; 2011 Jun; 25(10):1317-27. PubMed ID: 21522005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disinhibition in risky sexual behavior in men, but not women, during four years of antiretroviral therapy in rural, southwestern Uganda.
    Kembabazi A; Bajunirwe F; Hunt PW; Martin JN; Muzoora C; Haberer JE; Bangsberg DR; Siedner MJ
    PLoS One; 2013; 8(7):e69634. PubMed ID: 23894514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to Early Antiretroviral Therapy: Results From HPTN 052, a Phase III, Multinational Randomized Trial of ART to Prevent HIV-1 Sexual Transmission in Serodiscordant Couples.
    Safren SA; Mayer KH; Ou SS; McCauley M; Grinsztejn B; Hosseinipour MC; Kumarasamy N; Gamble T; Hoffman I; Celentano D; Chen YQ; Cohen MS;
    J Acquir Immune Defic Syndr; 2015 Jun; 69(2):234-40. PubMed ID: 26009832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risky sexual behavior among patients on long-term antiretroviral therapy: a prospective cohort study in urban and rural Uganda.
    Okoboi S; Castelnuovo B; Moore DM; Musaazi J; Kambugu A; Birungi J; Kaleebu P; Nanfuka M; Kamya MR; Van Rie A
    AIDS Res Ther; 2018 Oct; 15(1):15. PubMed ID: 30340608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual behaviors over a 3-year period among individuals with advanced HIV/AIDS receiving antiretroviral therapy in an urban HIV clinic in Kampala, Uganda.
    Wandera B; Kamya MR; Castelnuovo B; Kiragga A; Kambugu A; Wanyama JN; Easterbrook P; Sethi AK
    J Acquir Immune Defic Syndr; 2011 May; 57(1):62-8. PubMed ID: 21297481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of Antiretroviral Therapy Adherence Interruption Is Associated With Risk of Virologic Rebound as Determined by Real-Time Adherence Monitoring in Rural Uganda.
    Haberer JE; Musinguzi N; Boum Y; Siedner MJ; Mocello AR; Hunt PW; Martin JN; Bangsberg DR
    J Acquir Immune Defic Syndr; 2015 Dec; 70(4):386-92. PubMed ID: 26110445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WHO 'Treatment as Prevention' guidelines are unlikely to decrease HIV transmission in the UK unless undiagnosed HIV infections are reduced.
    Brown AE; Nardone A; Delpech VC
    AIDS; 2014 Jan; 28(2):281-3. PubMed ID: 24361685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief Report: Appraising Viral Load Thresholds and Adherence Support Recommendations in the World Health Organization Guidelines for Detection and Management of Virologic Failure.
    McCluskey SM; Boum Y; Musinguzi N; Haberer JE; Martin JN; Hunt PW; Marconi VC; Bangsberg DR; Siedner MJ
    J Acquir Immune Defic Syndr; 2017 Oct; 76(2):183-187. PubMed ID: 28628529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population prevalence of antiretroviral therapy sharing and its association with HIV viremia in rural Uganda: a cross-sectional population-based study.
    Kennedy CE; Feng X; Ssekubugu R; Rosen JG; Ssekasanvu J; Kigozi G; Serwadda D; Yeh PT; Kagaayi J; Quinn TC; Tobian AAR; Wawer MJ; Reynolds SJ; Chang LW; Grabowski MK; Nalugoda F
    J Int AIDS Soc; 2023 Sep; 26(9):e26135. PubMed ID: 37705364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
    Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM
    J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy.
    Reynolds SJ; Makumbi F; Nakigozi G; Kagaayi J; Gray RH; Wawer M; Quinn TC; Serwadda D
    AIDS; 2011 Feb; 25(4):473-7. PubMed ID: 21160416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing Prevalence of HIV Pretreatment Drug Resistance in Women But Not Men in Rural Uganda During 2005-2013.
    McCluskey SM; Lee GQ; Kamelian K; Kembabazi A; Musinguzi N; Bwana MB; Muzoora C; Haberer JE; Hunt PW; Martin JN; Boum Y; Bangsberg DR; Harrigan PR; Siedner MJ
    AIDS Patient Care STDS; 2018 Jul; 32(7):257-264. PubMed ID: 29985647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol use and HIV serostatus of partner predict high-risk sexual behavior among patients receiving antiretroviral therapy in South Western Uganda.
    Bajunirwe F; Bangsberg DR; Sethi AK
    BMC Public Health; 2013 May; 13():430. PubMed ID: 23641795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.
    Donnell D; Baeten JM; Kiarie J; Thomas KK; Stevens W; Cohen CR; McIntyre J; Lingappa JR; Celum C;
    Lancet; 2010 Jun; 375(9731):2092-8. PubMed ID: 20537376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ cell count at antiretroviral therapy initiation and economic restoration in rural Uganda.
    Venkataramani AS; Thirumurthy H; Haberer JE; Ii YB; Siedner MJ; Kembabazi A; Hunt PW; Martin JN; Bangsberg DR; Tsai AC
    AIDS; 2014 May; 28(8):1221-6. PubMed ID: 24406678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral therapy and sexual behavior in Uganda: a cohort study.
    Shafer LA; Nsubuga RN; White R; Mayanja BN; Chapman R; O'brien K; Van der Paal L; Grosskurth H; Maher D
    AIDS; 2011 Mar; 25(5):671-8. PubMed ID: 21252634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of early antiretroviral therapy eligibility on HIV acquisition: household-level evidence from rural South Africa.
    Oldenburg CE; Bor J; Harling G; Tanser F; Mutevedzi T; Shahmanesh M; Seage GR; De Gruttola V; Mimiaga MJ; Mayer KH; Pillay D; Bärnighausen T
    AIDS; 2018 Mar; 32(5):635-643. PubMed ID: 29334546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.